Persons with dispensed medicines; age and sex

Persons with dispensed medicines; age and sex

Sex Ages Medicine group (ATC) Periods Persons with medicines, relative (%)
Total male and female Total age C01D Vasodilators used in card. diseases 2022* 1.40
Total male and female Total age M05 Drugs for treatment of bone diseases 2022* 1.23
Total male and female Total age R03 Drugs for obstruct. airway diseases 2022* 8.38
Total male and female 0 to 15 years C01D Vasodilators used in card. diseases 2022* 0.00
Total male and female 0 to 15 years M05 Drugs for treatment of bone diseases 2022* 0.00
Total male and female 0 to 15 years R03 Drugs for obstruct. airway diseases 2022* 6.56
Total male and female 15 to 25 years C01D Vasodilators used in card. diseases 2022* 0.00
Total male and female 15 to 25 years M05 Drugs for treatment of bone diseases 2022* 0.01
Total male and female 15 to 25 years R03 Drugs for obstruct. airway diseases 2022* 4.65
Total male and female 25 to 35 years C01D Vasodilators used in card. diseases 2022* 0.02
Total male and female 25 to 35 years M05 Drugs for treatment of bone diseases 2022* 0.04
Total male and female 25 to 35 years R03 Drugs for obstruct. airway diseases 2022* 4.87
Total male and female 35 to 45 years C01D Vasodilators used in card. diseases 2022* 0.12
Total male and female 35 to 45 years M05 Drugs for treatment of bone diseases 2022* 0.11
Total male and female 35 to 45 years R03 Drugs for obstruct. airway diseases 2022* 6.08
Total male and female 45 to 55 years C01D Vasodilators used in card. diseases 2022* 0.65
Total male and female 45 to 55 years M05 Drugs for treatment of bone diseases 2022* 0.42
Total male and female 45 to 55 years R03 Drugs for obstruct. airway diseases 2022* 8.13
Total male and female 55 to 65 years C01D Vasodilators used in card. diseases 2022* 1.77
Total male and female 55 to 65 years M05 Drugs for treatment of bone diseases 2022* 1.55
Total male and female 55 to 65 years R03 Drugs for obstruct. airway diseases 2022* 10.68
Total male and female 65 to 75 years C01D Vasodilators used in card. diseases 2022* 3.50
Total male and female 65 to 75 years M05 Drugs for treatment of bone diseases 2022* 3.46
Total male and female 65 to 75 years R03 Drugs for obstruct. airway diseases 2022* 13.76
Total male and female 75 years or older C01D Vasodilators used in card. diseases 2022* 6.95
Total male and female 75 years or older M05 Drugs for treatment of bone diseases 2022* 5.83
Total male and female 75 years or older R03 Drugs for obstruct. airway diseases 2022* 14.56
Total male and female 0 to 5 years C01D Vasodilators used in card. diseases 2022* 0.00
Total male and female 0 to 5 years M05 Drugs for treatment of bone diseases 2022* 0.00
Total male and female 0 to 5 years R03 Drugs for obstruct. airway diseases 2022* 9.25
Total male and female 5 to 10 years C01D Vasodilators used in card. diseases 2022* 0.00
Total male and female 5 to 10 years M05 Drugs for treatment of bone diseases 2022* 0.00
Total male and female 5 to 10 years R03 Drugs for obstruct. airway diseases 2022* 5.96
Total male and female 10 to 15 years C01D Vasodilators used in card. diseases 2022* 0.00
Total male and female 10 to 15 years M05 Drugs for treatment of bone diseases 2022* 0.00
Total male and female 10 to 15 years R03 Drugs for obstruct. airway diseases 2022* 4.70
Total male and female 15 to 20 years C01D Vasodilators used in card. diseases 2022* 0.00
Total male and female 15 to 20 years M05 Drugs for treatment of bone diseases 2022* 0.01
Total male and female 15 to 20 years R03 Drugs for obstruct. airway diseases 2022* 4.86
Total male and female 20 to 25 years C01D Vasodilators used in card. diseases 2022* 0.00
Total male and female 20 to 25 years M05 Drugs for treatment of bone diseases 2022* 0.02
Total male and female 20 to 25 years R03 Drugs for obstruct. airway diseases 2022* 4.47
Total male and female 25 to 30 years C01D Vasodilators used in card. diseases 2022* 0.01
Total male and female 25 to 30 years M05 Drugs for treatment of bone diseases 2022* 0.04
Total male and female 25 to 30 years R03 Drugs for obstruct. airway diseases 2022* 4.70
Total male and female 30 to 35 years C01D Vasodilators used in card. diseases 2022* 0.02
Total male and female 30 to 35 years M05 Drugs for treatment of bone diseases 2022* 0.05
Total male and female 30 to 35 years R03 Drugs for obstruct. airway diseases 2022* 5.04
Total male and female 35 to 40 years C01D Vasodilators used in card. diseases 2022* 0.07
Total male and female 35 to 40 years M05 Drugs for treatment of bone diseases 2022* 0.08
Total male and female 35 to 40 years R03 Drugs for obstruct. airway diseases 2022* 5.64
Total male and female 40 to 45 years C01D Vasodilators used in card. diseases 2022* 0.18
Total male and female 40 to 45 years M05 Drugs for treatment of bone diseases 2022* 0.14
Total male and female 40 to 45 years R03 Drugs for obstruct. airway diseases 2022* 6.54
Total male and female 45 to 50 years C01D Vasodilators used in card. diseases 2022* 0.43
Total male and female 45 to 50 years M05 Drugs for treatment of bone diseases 2022* 0.26
Total male and female 45 to 50 years R03 Drugs for obstruct. airway diseases 2022* 7.59
Total male and female 50 to 55 years C01D Vasodilators used in card. diseases 2022* 0.84
Total male and female 50 to 55 years M05 Drugs for treatment of bone diseases 2022* 0.55
Total male and female 50 to 55 years R03 Drugs for obstruct. airway diseases 2022* 8.57
Total male and female 55 to 60 years C01D Vasodilators used in card. diseases 2022* 1.41
Total male and female 55 to 60 years M05 Drugs for treatment of bone diseases 2022* 1.15
Total male and female 55 to 60 years R03 Drugs for obstruct. airway diseases 2022* 9.78
Total male and female 60 to 65 years C01D Vasodilators used in card. diseases 2022* 2.15
Total male and female 60 to 65 years M05 Drugs for treatment of bone diseases 2022* 1.99
Total male and female 60 to 65 years R03 Drugs for obstruct. airway diseases 2022* 11.64
Total male and female 65 to 70 years C01D Vasodilators used in card. diseases 2022* 3.01
Total male and female 65 to 70 years M05 Drugs for treatment of bone diseases 2022* 2.94
Total male and female 65 to 70 years R03 Drugs for obstruct. airway diseases 2022* 13.42
Total male and female 70 to 75 years C01D Vasodilators used in card. diseases 2022* 4.06
Total male and female 70 to 75 years M05 Drugs for treatment of bone diseases 2022* 4.02
Total male and female 70 to 75 years R03 Drugs for obstruct. airway diseases 2022* 14.14
Total male and female 75 to 80 years C01D Vasodilators used in card. diseases 2022* 5.30
Total male and female 75 to 80 years M05 Drugs for treatment of bone diseases 2022* 5.17
Total male and female 75 to 80 years R03 Drugs for obstruct. airway diseases 2022* 14.45
Total male and female 80 to 85 years C01D Vasodilators used in card. diseases 2022* 7.10
Total male and female 80 to 85 years M05 Drugs for treatment of bone diseases 2022* 6.41
Total male and female 80 to 85 years R03 Drugs for obstruct. airway diseases 2022* 15.03
Total male and female 85 to 90 years C01D Vasodilators used in card. diseases 2022* 9.16
Total male and female 85 to 90 years M05 Drugs for treatment of bone diseases 2022* 6.93
Total male and female 85 to 90 years R03 Drugs for obstruct. airway diseases 2022* 14.95
Total male and female 90 years or older C01D Vasodilators used in card. diseases 2022* 10.29
Total male and female 90 years or older M05 Drugs for treatment of bone diseases 2022* 5.37
Total male and female 90 years or older R03 Drugs for obstruct. airway diseases 2022* 13.05
Male Total age C01D Vasodilators used in card. diseases 2022* 1.60
Male Total age M05 Drugs for treatment of bone diseases 2022* 0.59
Male Total age R03 Drugs for obstruct. airway diseases 2022* 7.48
Male 0 to 15 years C01D Vasodilators used in card. diseases 2022* 0.00
Male 0 to 15 years M05 Drugs for treatment of bone diseases 2022* 0.00
Male 0 to 15 years R03 Drugs for obstruct. airway diseases 2022* 7.75
Male 15 to 25 years C01D Vasodilators used in card. diseases 2022* 0.00
Male 15 to 25 years M05 Drugs for treatment of bone diseases 2022* 0.01
Male 15 to 25 years R03 Drugs for obstruct. airway diseases 2022* 4.04
Male 25 to 35 years C01D Vasodilators used in card. diseases 2022* 0.02
Male 25 to 35 years M05 Drugs for treatment of bone diseases 2022* 0.04
Male 25 to 35 years R03 Drugs for obstruct. airway diseases 2022* 3.86
Male 35 to 45 years C01D Vasodilators used in card. diseases 2022* 0.14
Male 35 to 45 years M05 Drugs for treatment of bone diseases 2022* 0.09
Male 35 to 45 years R03 Drugs for obstruct. airway diseases 2022* 4.69
Male 45 to 55 years C01D Vasodilators used in card. diseases 2022* 0.80
Source: CBS.
Explanation of symbols

Dataset is not available.


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, age and sex.

Data available from: 2006

Status of the figures:
Figures for 2022 are provisional.

Changes as of December 20, 2023:
- Provisional figures for 2022 have been added, provisional figures of 2020 and 2021 have been made definite.
- Textual change: the description of drug group Y (Not filled in) has been replaced by Z (Not applicable). However, the underlying resources have remained the same. This category is assigned to products that do not have an ATC code according to the WHO ATC classification system.

When will new figures be published?
New figures will be published in the last quarter of 2024.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.